Skip to content

Effect of Mulberry Fruit Powder in Metabolic Syndrome

Therapeutic Effect of Mulberry Fruit Powder Consumption in Metabolic Syndrome

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05956106
Enrollment
40
Registered
2023-07-21
Start date
2023-08-01
Completion date
2023-12-01
Last updated
2023-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Keywords

Hypertension, Diabetes, Obesity, Hyperlipidemia, Mulberry, Anthocyanin

Brief summary

Metabolic syndrome is a raising concern globally, especially in developing countries such as Pakistan. To prevent its risk factors diet and lifestyle modification is major solution. Functional foods have additional benefits of treating disease while providing basic nutrients. Mulberry is a native fruit with the properties of functional food, it is rich in anthocyanin and different anti-obesity,anti-diabetic, and anti-hyperlipidemic treating potential antioxidants. Mulberry will prove its therapeutic potential against the risk factors of metabolic syndrome.

Detailed description

Metabolic syndrome, which is characterized by a number of concurrent risk factors. These risk factors include dysglycemia, high blood pressure, high triglyceride levels, low levels of HDL cholesterol, and obesity (particularly central adiposity). It is rapidly increasing the burden of non-communicable diseases (NCDs) in Pakistan. The prevalence of MetS in Pakistan is 28.6%, and suburban areas from the province of Punjab showed a high prevalence. Females are more prone to metabolic syndrome. Dietary and lifestyle modification can prevent MetS from converting into CVD, T2DM, and stroke. There is limited documented research in Pakistan related to the therapeutic roles of mulberry fruit powder. With respect to these limitations, the present study aims to assess the therapeutic roles of mulberry fruit powder consumption on metabolic syndrome. The utilization of dried mulberry fruit powder (MFP) as a component of nutritional supplementation will effectively ameliorate the clinical markers associated with metabolic syndrome.

Interventions

DIETARY_SUPPLEMENTBlack Mulberry Fruit Powder

Anthocyanin plays a major role in preventing symptoms of metabolic syndrome.

Sponsors

University of Veterinary and Animal Sciences, Lahore - Pakistan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

Participants groups

Intervention model description

Case-Control Study

Eligibility

Sex/Gender
ALL
Age
35 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Subjects having fasting total cholesterol level of ≥ 200 mg/dl or LDL cholesterol ≥ 130 mg/dl. * Fasting Blood Glucose ≥110mg/dl. * SBP ≥ 130/ ≥ 85 mmHg * Waist Circumference of ≥40 inches in males and ≥35 inches for females

Exclusion criteria

* Participants of age 55 or above * Participants who have less than two risk factors

Design outcomes

Primary

MeasureTime frameDescription
Lipid profile will be assessed before and after the trial.45 daysThe change in lipid profile, after consuming mulberry fruit powder for 45 days, will be assessed. The value will be closed to optimized values.
Fasting glucose level will be assessed before and after the trial45 daysThe change in fasting glucose levels will be assessed after consuming mulberry fruit powder for 45 days.The values will be become close to optimized levels
Weight circumference will be measured before and after the trial45 daysThe change in weight will be measured after consuming mulberry fruit powder for 45 days.The value will be close to normal range.
Blood pressure will be assessed before and after the trial.45 daysThe change in systolic and diastolic blood pressure, after consuming mulberry fruit powder for 45 days. The values will become close to optimized levels.

Countries

Pakistan

Contacts

Primary ContactFiza Maqbool, DNS
fizach65@gmail.com03008077414

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026